TY - JOUR T1 - Cardiovascular risk management in COPD patients: impact of the new Dutch guideline JF - BJGP Open JO - BJGP Open DO - 10.3399/bjgpopen20X101139 SP - bjgpopen20X101139 AU - Lonneke Maria Elisabeth Nies AU - Looijmans I AU - Rozendaal Rozendaal AU - Brenda Baar AU - Rimke C Vos AU - Huberta E Hart Y1 - 2020/11/17 UR - http://bjgpopen.org/content/early/2020/11/12/bjgpopen20X101139.abstract N2 - Background: Patients with COPD have an independent increased risk of cardiovascular (CV) disease. CV-risk (CVR) assessment should be offered to all COPD-patients according to the new Dutch ‘CVR management’ (CVRM) guideline (May-2019). Aim: To evaluate the impact of this new guideline for the care of COPD-patients in primary care. Design and Setting: A retrospective study within five primary healthcare centres located in the Netherlands. Methods: In accordance with the guideline we estimated and categorized the CVR of all COPD-patients. Data from 2014–2019 were used for the qualitative risk assessment based on comorbidities, and the quantitative Systematic Coronary Risk Assessment (SCORE). In addition, we investigated the guideline-based follow-up. Results: Of the 391 COPD-patients, 84.1% (n=329) had complete data on CVR assessment: 90.3% (n=297) had a (very)-high risk and 9.7% (n=32) a low-to-moderate risk. Of the patients with (very)-high risk, 73.4% (n=218) received guideline-based follow-up (primary care: 95.4%, secondary care: 4.6%). In 15.9% (n=62) of all COPD-patients, the CVR profile was not measured and of the (very)-high-risk patients, 26.6% (n=79) was not enrolled in a CV-care program. Conclusion: Whereas in the majority of patients the CVR is already known, for one out of six COPD-patients this CVR still has to be assessed according to the recently updated guideline. Moreover, once a (very)-high risk has been assessed, as a consequence CV treatment of risk factors should be intensified in one out of four COPD-patients. Adherence to the new CVRM guideline could provide improvement in CVRM in more than a third of all COPD-patients. ER -